Cargando…

Emerging Therapies for Dystrophic Cardiomyopathy

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Garry, Daniel J., Alexy, Tamas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978550/ https://www.ncbi.nlm.nih.gov/pubmed/31999276 http://dx.doi.org/10.1016/j.jacbts.2019.10.003

Ejemplares similares

COVID cardiomyopathy: Is it time to involve the cardiologists?
por: Chowdhury, Mohammed, et al.
Publicado: (2020)

To Breastfeed or Not to Breastfeed With Peripartum Cardiomyopathy
por: Arany, Zoltan, et al.
Publicado: (2019)

Paracrine Factors in Uremic Cardiomyopathy
por: Sucharov, Carmen C.
Publicado: (2020)

Takotsubo cardiomyopathy – stunning views on the broken heart
por: Teske, A. J., et al.
Publicado: (2016)

Echocardiography in takotsubo cardiomyopathy; a useful approach?
por: van der Wall, E. E., et al.
Publicado: (2010)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

Role of the Extracellular Matrix in the Pathogenesis of Hypertrophic Cardiomyopathy
por: Marian, Ali J.
Publicado: (2019)

Modeling Human Dilated Cardiomyopathy Using Humans
por: Gacita, Anthony M., et al.
Publicado: (2018)

Dystrophic cardiomyopathy: role of the cardiac myofilaments
por: George, Thomas G., et al.
Publicado: (2023)

Variable Morphology of Stress-Induced Cardiomyopathy
por: Ryu, Dong Ryeol
Publicado: (2013)

Detection of apical hypertrophic cardiomyopathy; which is the appropriate imaging modality
por: van der Wall, E. E., et al.
Publicado: (2008)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?
por: van der Wall, E. E.
Publicado: (2009)

Dystrophic Cardiomyopathy—Potential Role of Calcium in Pathogenesis, Treatment and Novel Therapies
por: Johnstone, Victoria P. A., et al.
Publicado: (2017)

Right ventricular function in dilated cardiomyopathy: women are the stronger sex!
por: Merkus, D.
Publicado: (2015)

The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy
por: van der Heijden, J. F., et al.
Publicado: (2013)

The Role of Mecahnical Dyssynchrony on Functional Mitral Regurgitation in Patients with Dilated Cardiomyopathy
por: Kim, Jang-Young
Publicado: (2011)

Revolutionizing cardiovascular medicine: targeted therapies for the cardiac conduction system
por: Garry, Daniel J., et al.
Publicado: (2022)

New therapies to treat inherited cardiomyopathies are on the way
por: Vlasman, P., et al.
Publicado: (2022)

DNA Damage Prediction Tool in Dilated Cardiomyopathy: Don’t Go Breaking My Heart
por: Jimenez, Jesus, et al.
Publicado: (2019)

Three’s Company: A Rare Case of a Myocardial Bridge With Concomitant SCAD and Takotsubo Cardiomyopathy
por: Gianos, Eugenia, et al.
Publicado: (2021)

The role of P-wave dispersion in dystrophic and thalassemic cardiomyopathy
por: Russo, Vincenzo, et al.
Publicado: (2017)

Histologic Sequelae of Apical Hypertrophic Cardiomyopathy: Dystrophic Calcification
por: Saba, Shahryar G, et al.
Publicado: (2017)

Three dimensional echocardiography: a valuable tool to assess left atrial function in non-compaction cardiomyopathy!
por: Baur, Leo H. B.
Publicado: (2007)

How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. J. Clin. Med. 2023, 12, 1412
por: Kataoka, Naoya, et al.
Publicado: (2023)

JPH2 Mutant Gene Causes Familial Hypertrophic Cardiomyopathy: A Possible Model to Unravel the Subtlety of Calcium-Regulated Contractility
por: Roberts, Robert
Publicado: (2017)

Percutaneous Septal Reduction Therapy in a Patient with Severely Symptomatic Hypertrophic Obstructive Cardiomyopathy: An experience from a tertiary care centre
por: Al Lawati, Hatim, et al.
Publicado: (2022)

Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype
por: Tsuda, Takeshi, et al.
Publicado: (2017)

CD24Fc: an emerging COVID-19 therapy
por: Eckhardt, Christina M, et al.
Publicado: (2022)

The history of the cardiac emergency room, and the patient’s history
por: Peters, R. J. G.
Publicado: (2014)

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs
por: Abassi, Zaid, et al.
Publicado: (2015)

The Emerging Role of Circular RNAs in Cardio-Oncology
por: Gao, Chen, et al.
Publicado: (2023)

Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
por: Heier, Christopher R, et al.
Publicado: (2019)

Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic
por: Mohr-Holland, Erika, et al.
Publicado: (2021)

Role of Echocardiography in Diagnosing Myocardial Ischemia at Emergency Department
por: Cho, Kyoung Im
Publicado: (2017)

Long‐Term miR‐669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice
por: Quattrocelli, Mattia, et al.
Publicado: (2013)

Antiplatelet therapy following TAVI: time to randomise
por: Delewi, R., et al.
Publicado: (2014)

Pulmonary Arteriovenous Malformations and the Hepatic “Black Box”: Are We Emerging From the Darkness?
por: Rajagopal, Satish K., et al.
Publicado: (2021)

“The new normal”? Lessons from the treatment of emerging infectious diseases with old drugs
por: Baptista, Maria João
Publicado: (2022)

Cardiac resynchronization therapy; evaluation by advanced imaging techniques
por: van der Wall, E. E., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ivsrgdmu2fqe98b3b1furvsggp